Successful therapy reduces levels of vascular endothelial growth factor (VEGF) in patients with hypertension and patients with hypercholesterolemia

被引:16
作者
Belgore, FM [1 ]
Lip, GYH [1 ]
Blann, AD [1 ]
机构
[1] Univ Birmingham, City Hosp, Dept Med, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham B18 7QH, W Midlands, England
关键词
vascular endothelial growth factor; hypercholesterolemia; hypertension;
D O I
10.1016/S0021-9150(00)00477-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:599 / 599
页数:1
相关论文
共 4 条
[1]  
BELGORE FM, 1999, BLOOD COAG FIBRIN, P10
[2]  
MALONEY JP, 1998, HEART CIRC PHYSL, V44, pH1054
[3]   Serum level of vascular endothelial growth factor is decreased by hormone replacement therapy in postmenopausal women without hypercholesterolemia [J].
Sumino, H ;
Nakamura, T ;
Ichikawa, S ;
Kanda, T ;
Sakamaki, T ;
Sato, K ;
Kobayashi, I ;
Nagai, R .
ATHEROSCLEROSIS, 2000, 148 (01) :189-195
[4]   Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease [J].
Webb, NJA ;
Bottomley, MJ ;
Watson, CJ ;
Brenchley, PEC .
CLINICAL SCIENCE, 1998, 94 (04) :395-404